
Please refer to the manufacturer‘s website to learn all the information needed to use this medicine safely and effectively.
$868.00 USD
Pivikto® is an authorized generic of Piqray® used, in combination with fulvestrant, to treat breast cancer in men and postmenopausal women that is HR-positive, HER2-negative, PIK3CA-mutated, and is advanced or has spread to other parts of the body following progression on or after an endocrine-based regimen.
Package Size : 28 Tablets
Active Ingredient : Alpelisib 150 MG
Manufactured by Novartis AG®
Product of Switzerland
No prescription? Do you have a used Alpelisib box with your info printed on it? Click here
Delivery of this medication is fully guaranteed and takes 8 to 14 days by Express Mail
In stock
Reviews
There are no reviews yet.